fashion -WSS

fashion

author：fashion 2025-09-29 21:13:48 - browse：78359

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl Icahn.

During the battle, there had been speculation that Jay Flatley, deSouza’s predecessor, could return. Under Flatley, Illumina had grown from an upstart to the dominant player in a field that has proved pivotal for medical research and delivered sizable returns to investors.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Cognito secures funding to test medical device for Alzheimer's

hotspot

WSS

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Apple Vision Pro: A first look at health apps on the new VR headset

Quicker fix for pulse oximeters urged during FDA public meeting

Bernie brings in new pharma CEOs to talk drug prices

Vertigo drug brings hope for rare neuron disorder, Niemann

Cybersecurity threat forces Lurie Children's to take systems offline

leisure time

fashion

leisure time

Apple is now the first public company to be valued at $3 trillion

Biden administration opens offers in Medicare drug price negotiations

In age of alternative facts, a scholarly course on calling out crap

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Tori Bowie and the unacceptable rates of Black maternal death

Adopting new red light myopia treatments may be short

Peter Hotez and the public health issue of online harassment

Commercial surrogacy can be ethical, despite pope’s claims

Cancer drug shortages should be causing more outrage

Problems with a popular proposal to regulate AI in health care

knowledge

Gene therapy for Afghan refugees’ infant will be fully covered

A $475,000 price tag for a new cancer drug: crazy or meh?

Commercial surrogacy can be ethical, despite pope’s claims

Problems with a popular proposal to regulate AI in health care

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Biden administration opens offers in Medicare drug price negotiations

focus

knowledge

hotspot

leisure time